Identification of Specific Biomarkers and Pathways in the Treatment Response of Infliximab for Inflammatory Bowel Disease: In-Silico Analysis.

Rachid Kaddoura,Hardik Ghelani,Fatma Alqutami, Hala Altaher,Mahmood Hachim,Reem Kais Jan

Life (Basel, Switzerland)（2023）

引用 0|浏览0

暂无评分

摘要

We hypothesize that alteration in the expression of these genes leads to an impaired response to infliximab in IBD patients. Thus, these genes can serve as potential biomarkers for the early detection of compromised infliximab response in IBD patients.

查看译文

关键词

differentially expressed gene analysis,in-silico,inflammatory bowel disease,infliximab treatment response,transcriptomics

AI 理解论文

溯源树

样例

生成溯源树，研究论文发展脉络

Chat Paper

正在生成论文摘要